Literature DB >> 7672051

Diagnosis of bronchopulmonary infections by quantification of microflora.

F Pirali1, M Longo, M Gelmi, D Colombrita, G Ravizzola, G Pinsi, L Peroni, N Manca, A Turano.   

Abstract

The quantification of bacteria and fungi in sputum or bronchoaspirate is of clinical value for the diagnosis of respiratory tract infections. We have developed an easy method to count the micro-organisms in patients with respiratory tract infections. This consists of the quantification of micro-organisms by subsequent streakings of a calibrated loop on agar. The correlation between microbiological quantitative data and the clinical status of patients with lower respiratory tract infections is discussed. The data seem to indicate that certain bacteria present in sputum or bronchoaspirate above a certain concentration may be responsible for lower respiratory tract infections. In patients with immunological disorders or chronic pathologies even lower concentrations of micro-organisms in bronchial secretions probably are enough to cause infections. The advantage of this counting method of the microbic species from the respiratory tract consists of their quantification: thus we can attribute an etiological role to a high concentration of the germs, while micro-organisms at low concentrations are probably contaminants. By this method isolated colonies are obtained after 12-18 hours. The bacterial quantification, by respiratory samples examination of the same patient in the following days, allows us to evaluate the efficacy of antibacterial therapy, producing a reduction of bacterial concentration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7672051     DOI: 10.1007/bf01719285

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  13 in total

1.  [Bacteriological examination of sputum (author's transl)].

Authors:  V Bernardini; G Berra
Journal:  Ann Sclavo       Date:  1976 Mar-Apr

2.  Quantitative culture of bronchoalveolar lavage from patients with anaerobic lung abscesses.

Authors:  A H Henriquez; J Mendoza; P C Gonzalez
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

3.  Rapid detection and identification of mycobacteria from blood of patients with acquired immune deficiency syndrome.

Authors:  D Colombrita; G Ravizzola; G Pinsi; R Li Vigni; F Pirali; A Turano
Journal:  J Med Microbiol       Date:  1990-08       Impact factor: 2.472

4.  Semiquantitation of bacteria in sputum gram stains.

Authors:  P N Valenstein
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

5.  Quantitative bacteriology of sputum.

Authors:  J P Kilbourn; R A Campbell; J L Grach; M D Willis
Journal:  Am Rev Respir Dis       Date:  1968-11

6.  Use of selective media in bacteriological investigation of patients with chronic suppurative respiratory infection.

Authors:  D E Roberts; P Cole
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

7.  [Bacterial counts in sputum. The value and interpretation in lower respiratory tract infections (author's transl)].

Authors:  A Chaste; M C Level; M Scavizzi
Journal:  Rev Fr Mal Respir       Date:  1980

8.  [Quantitative cytobacteriological study of sputum in chronic bronchitics (author's transl)].

Authors:  G Beck; E Puchelle; J M Polu
Journal:  Rev Fr Mal Respir       Date:  1980

9.  Quantitation of microorganisms in sputum.

Authors:  P W Monroe; H G Muchmore; F G Felton; J K Pirtle
Journal:  Appl Microbiol       Date:  1969-08

10.  The incidence of anaerobes in the sputum of patients with cystic fibrosis.

Authors:  L A Jewes; R C Spencer
Journal:  J Med Microbiol       Date:  1990-04       Impact factor: 2.472

View more
  2 in total

1.  Accuracy and precision of quantitative calibrated loops in transfer of bronchoalveolar lavage fluid.

Authors:  J A Jacobs; E I De Brauwer; E I Cornelissen; M Drent
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.

Authors:  T W Felton; J Goodwin; L O'Connor; A Sharp; L Gregson; J Livermore; S J Howard; M N Neely; W W Hope
Journal:  Antimicrob Agents Chemother       Date:  2013-09-03       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.